✦ LIBER ✦

Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia

✍ Scribed by Frans Debruyne; Jack Barkin; Peter van Erps; Mario Reis; Teuvo L.J. Tammela; Claus Roehrborn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term therapy with the dual 5α-reduc

✍ CLAUDE SCHULMAN; PETER POMMERVILLE; KLAUS HÖFNER; BARTON WACHS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Commentaire de l'article “Efficacy and s

✍ François Desgrandchamps 📂 Article 📅 2004 🏛 Elsevier Science 🌐 French ⚖ 71 KB

Safety and Tolerability of the Dual 5α-R

✍ Gerald L Andriole; Roger Kirby 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Efficacy and safety of a dual inhibitor

✍ Claus G Roehrborn; Peter Boyle; J.Curtis Nickel; Klaus Hoefner; Gerald Andriole 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Long-term sustained improvement in sympt

✍ Claus G. Roehrborn; Olavi Lukkarinen; Stephen Mark; Paul Siami; Joe Ramsdell; No 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Efficacy and safety of dutasteride in th

✍ Claus G Roehrborn; Leonard S Marks; Tom Fenter; Sheldon Freedman; John Tuttle; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 219 KB